{"count": 4, "results": [{"_id": "39907424", "pmid": 39907424, "title": "Clenbuterol and metformin ameliorate cachexia parameters, but only clenbuterol reduces tumor growth via lipid peroxidation in Walker 256 tumor-bearing rats.", "journal": "Braz J Med Biol Res", "authors": ["Henschel LDV", "Lima MER", "Fagundes FC", "Horlem T", "Zazula MF", "Naliwaiko K", "Fernandes LC"], "date": "2025-01-31T00:00:00Z", "doi": "10.1590/1414-431X2024e14060", "meta_date_publication": "2025", "meta_volume": "58", "meta_issue": "", "meta_pages": "e14060", "score": 50253.496, "text_hl": "@CHEMICAL_Clenbuterol @CHEMICAL_MESH:D002976 @@@Clenbuterol@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ameliorate @<m>DISEASE_Cachexia</m> @DISEASE_MESH:D002100 @@@cachexia@@@ parameters, but only @CHEMICAL_Clenbuterol @CHEMICAL_MESH:D002976 @@@clenbuterol@@@ reduces @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ growth via @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ peroxidation in @CELLLINE_CVCL:3537 @@@Walker 256 tumor@@@-bearing @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Henschel LDV, Lima MER, Fagundes FC, Horlem T, Zazula MF, Naliwaiko K, Fernandes LC. Clenbuterol and metformin ameliorate cachexia parameters, but only clenbuterol reduces tumor growth via lipid peroxidation in Walker 256 tumor-bearing rats. Braz J Med Biol Res. 2025;58():e14060. PMID: 39907424", "BibTeX": "@article{39907424, title={Clenbuterol and metformin ameliorate cachexia parameters, but only clenbuterol reduces tumor growth via lipid peroxidation in Walker 256 tumor-bearing rats.}, author={Henschel LDV and Lima MER and Fagundes FC and Horlem T and Zazula MF and Naliwaiko K and Fernandes LC}, journal={Braz J Med Biol Res}, volume={58}, pages={e14060}}"}}, {"_id": "27388367", "pmid": 27388367, "pmcid": "PMC4936094", "title": "Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats", "journal": "BMC Cancer", "authors": ["Oliveira AG", "Gomes-Marcondes MC"], "date": "2016-07-07T00:00:00Z", "doi": "10.1186/s12885-016-2424-9", "meta_date_publication": "2016 Jul 7", "meta_volume": "16", "meta_issue": "", "meta_pages": "418", "score": 50077.066, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment modulates the @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@-induced wasting effects in muscle protein metabolism minimising the @<m>DISEASE_Cachexia</m> @DISEASE_MESH:D002100 @@@cachexia@@@ in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@-bearing rats", "citations": {"NLM": "Oliveira AG, Gomes-Marcondes MC. Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats BMC Cancer. 2016 Jul 7;16():418. PMID: 27388367", "BibTeX": "@article{27388367, title={Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats}, author={Oliveira AG and Gomes-Marcondes MC}, journal={BMC Cancer}, volume={16}, pages={418}}"}}, {"_id": "25122066", "pmid": 25122066, "title": "Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.", "journal": "Mol Cancer Ther", "authors": ["Babcook MA", "Shukla S", "Fu P", "Vazquez EJ", "Puchowicz MA", "Molter JP", "Oak CZ", "MacLennan GT", "Flask CA", "Lindner DJ", "Parker Y", "Daneshgari F", "Gupta S"], "date": "2014-10-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-14-0451", "meta_date_publication": "2014 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "2288-302", "score": 50045.883, "text_hl": "Studies of @CELLLINE_CVCL:4787 @@@C4-2B4@@@ orthotopic NCr-nu/nu @SPECIES_10090 @@@mice@@@ further demonstrated that combination of @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (3.5-7.0 mug/g body weight @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 175-350 mug/g body weight @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) daily by oral gavage over a 9-week period significantly inhibited primary ventral @DISEASE_Prostatitis @DISEASE_MESH:D011472 @@@prostate tumor@@@ formation, @<m>DISEASE_Cachexia</m> @DISEASE_MESH:D002100 @@@cachexia@@@, @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@bone metastasis@@@, and biochemical failure more effectively than 24 mug/g body weight @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@ intraperitoneally injected every 3 weeks, 7.0 mug/g/day @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@, or 350 mug/g/day @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment alone, with significantly less @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ and mortality than @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@, establishing combination of @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a promising chemotherapeutic alternative for metastatic @DISEASE_Prostatic_Neoplasms_Castration_Resistant @DISEASE_MESH:D064129 @@@CRPC@@@.", "citations": {"NLM": "Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2288-302. PMID: 25122066", "BibTeX": "@article{25122066, title={Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.}, author={Babcook MA and Shukla S and Fu P and Vazquez EJ and Puchowicz MA and Molter JP and Oak CZ and MacLennan GT and Flask CA and Lindner DJ and Parker Y and Daneshgari F and Gupta S}, journal={Mol Cancer Ther}, volume={13}, number={10}, pages={2288-302}}"}}, {"_id": "24869969", "pmid": 24869969, "title": "Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.", "journal": "Appl Physiol Nutr Metab", "authors": ["Chevalier S", "Farsijani S"], "date": "2014-06-01T00:00:00Z", "doi": "10.1139/apnm-2013-0369", "meta_date_publication": "2014 Jun", "meta_volume": "39", "meta_issue": "6", "meta_pages": "643-53", "score": 50044.453, "text_hl": "Because the gradual @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@muscle loss@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ may be attenuated by @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ treatment, anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drugs might be considered in @<m>DISEASE_Cachexia</m> @DISEASE_MESH:D002100 @@@cachexia@@@ treatment. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ emerges as a choice candidate as it acts both on reducing gluconeogenesis and improving @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity, and has demonstrated @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ suppressor properties in multiple @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ types. ", "citations": {"NLM": "Chevalier S, Farsijani S. Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment. Appl Physiol Nutr Metab. 2014 Jun;39(6):643-53. PMID: 24869969", "BibTeX": "@article{24869969, title={Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.}, author={Chevalier S and Farsijani S}, journal={Appl Physiol Nutr Metab}, volume={39}, number={6}, pages={643-53}}"}}]}